feed,title,long_url,short_url
MarketWatch,Seres shares fall 55% after the company says its colitis drug failed in mid-stage clinical trial,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/t-ZIU9oSD2A/story.aspx,https://on.mktw.net/3BsCVgr
